ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-11 |

Results: 11

Use of saliva in therapeutic drug monitoring of caffeine in preterm infants

Authors: de Wildt, SN Kerkvliet, KTM Wezenberg, MGA Ottink, S Hop, WCJ Vulto, AG van den Anker, JN

Citation: Sn. De Wildt et al., Use of saliva in therapeutic drug monitoring of caffeine in preterm infants, THER DRUG M, 23(3), 2001, pp. 250-254

FDAMA's written request list: medicines for children

Authors: Jong, GW van den Anker, JN Choonara, I

Citation: Gw. Jong et al., FDAMA's written request list: medicines for children, LANCET, 357(9253), 2001, pp. 398-398

A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital

Authors: 't Jong, GW Vulto, AG de Hoog, M Schimmel, KJM Tibboel, D van den Anker, JN

Citation: Gw. 'T Jong et al., A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital, PEDIATRICS, 108(5), 2001, pp. 1089-1093

Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus

Authors: Van Overmeire, B Touw, D Schepens, PJC Kearns, GL van den Anker, JN

Citation: B. Van Overmeire et al., Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus, CLIN PHARM, 70(4), 2001, pp. 336-343

The CYP3A43 allele: Is it really rare?

Authors: van Schaik, RHN de Wildt, SN Brosens, R van Fessem, M van den Anker, JN Lindemans, J

Citation: Rhn. Van Schaik et al., The CYP3A43 allele: Is it really rare?, CLIN CHEM, 47(6), 2001, pp. 1104-1106

An antibiotic policy to prevent emergence of resistant bacilli

Authors: de Man, P Verhoeven, BAN Verbrugh, HA Vos, MC van den Anker, JN

Citation: P. De Man et al., An antibiotic policy to prevent emergence of resistant bacilli, LANCET, 355(9208), 2000, pp. 973-978

Unapproved and off-label use of drugs in a children's hospital

Authors: 'T Jong, GW Vulto, AG de Hoog, M Schimmel, KJM Tibboel, D van den Anker, JN

Citation: Gw. 'T Jong et al., Unapproved and off-label use of drugs in a children's hospital, N ENG J MED, 343(15), 2000, pp. 1125-1125

Vancomycin population pharmacokinetics in neonates

Authors: de Hoog, M Schoemaker, RC Mouton, JW van den Anker, JN

Citation: M. De Hoog et al., Vancomycin population pharmacokinetics in neonates, CLIN PHARM, 67(4), 2000, pp. 360-367

CYP3A4-V polymorphism detection by PCR-restriction fragment length polymorphism analysis and its allelic frequency among 199 Dutch Caucasians

Authors: van Schaik, RHN de Wildt, SN van Iperen, NM Uitterlinden, AG van den Anker, JN Lindemans, J

Citation: Rhn. Van Schaik et al., CYP3A4-V polymorphism detection by PCR-restriction fragment length polymorphism analysis and its allelic frequency among 199 Dutch Caucasians, CLIN CHEM, 46(11), 2000, pp. 1834-1836

Cytochrome P450 3A - Ontogeny and drug disposition

Authors: de Wildt, SN Kearns, GL Leeder, JS van den Anker, JN

Citation: Sn. De Wildt et al., Cytochrome P450 3A - Ontogeny and drug disposition, CLIN PHARMA, 37(6), 1999, pp. 485-505

Glucuronidation in humans - Pharmacogenetic and developmental aspects

Authors: de Wildt, SN Kearns, GL Leeder, JS van den Anker, JN

Citation: Sn. De Wildt et al., Glucuronidation in humans - Pharmacogenetic and developmental aspects, CLIN PHARMA, 36(6), 1999, pp. 439-452

Risultati: 1-11 |